Literature DB >> 18803886

Recent advances in understanding the molecular basis of group B Streptococcus virulence.

Heather C Maisey1, Kelly S Doran, Victor Nizet.   

Abstract

Group B Streptococcus commonly colonises healthy adults without symptoms, yet under certain circumstances displays the ability to invade host tissues, evade immune detection and cause serious invasive disease. Consequently, Group B Streptococcus remains a leading cause of neonatal pneumonia, sepsis and meningitis. Here we review recent information on the bacterial factors and mechanisms that direct host-pathogen interactions involved in the pathogenesis of Group B Streptococcus infection. New research on host signalling and inflammatory responses to Group B Streptococcus infection is summarised. An understanding of the complex interplay between Group B Streptococcus and host provides valuable insight into pathogen evolution and highlights molecular targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18803886      PMCID: PMC2676346          DOI: 10.1017/S1462399408000811

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  125 in total

1.  Capsular sialic acid limits C5a production on type III group B streptococci.

Authors:  S Takahashi; Y Aoyagi; E E Adderson; Y Okuwaki; J F Bohnsack
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding.

Authors:  Christiane Beckmann; Joshua D Waggoner; Theresa O Harris; Glen S Tamura; Craig E Rubens
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

3.  Group B streptococcal beta-hemolysin induces mortality and liver injury in experimental sepsis.

Authors:  Axel Ring; Johann S Braun; Jürgen Pohl; Victor Nizet; Wolfgang Stremmel; Jerry L Shenep
Journal:  J Infect Dis       Date:  2002-05-22       Impact factor: 5.226

4.  Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.

Authors:  Ravin Seepersaud; Sean B Hanniffy; Peter Mayne; Phil Sizer; Richard Le Page; Jerry M Wells
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8.

Authors:  Kelly S Doran; Jennifer C W Chang; Vivian M Benoit; Lars Eckmann; Victor Nizet
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

6.  Regulation of D-alanyl-lipoteichoic acid biosynthesis in Streptococcus agalactiae involves a novel two-component regulatory system.

Authors:  C Poyart; M C Lamy; C Boumaila; F Fiedler; P Trieu-Cuot
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

7.  Group B streptococcal beta-hemolysin promotes injury of lung microvascular endothelial cells.

Authors:  R L Gibson; V Nizet; C E Rubens
Journal:  Pediatr Res       Date:  1999-05       Impact factor: 3.756

8.  The group B streptococcal C5a peptidase is both a specific protease and an invasin.

Authors:  Qi Cheng; Deborah Stafslien; Sai Sudha Purushothaman; Patrick Cleary
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

9.  Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.

Authors:  Samira Dahesh; Mary E Hensler; Nina M Van Sorge; Robert E Gertz; Stephanie Schrag; Victor Nizet; Bernard W Beall
Journal:  Antimicrob Agents Chemother       Date:  2008-06-09       Impact factor: 5.191

10.  Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin.

Authors:  B Spellerberg; E Rozdzinski; S Martin; J Weber-Heynemann; N Schnitzler; R Lütticken; A Podbielski
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more
  81 in total

1.  Oxidative stress, cytokine/chemokine and disruption of blood-brain barrier in neonate rats after meningitis by Streptococcus agalactiae.

Authors:  Tatiana Barichello; Joelson C Lemos; Jaqueline S Generoso; Andreza L Cipriano; Graziele L Milioli; Danielle M Marcelino; Francieli Vuolo; Fabricia Petronilho; Felipe Dal-Pizzol; Márcia Carvalho Vilela; Antonio Lucio Teixeira
Journal:  Neurochem Res       Date:  2011-06-03       Impact factor: 3.996

2.  O-Acetylation of sialic acid on Group B Streptococcus inhibits neutrophil suppression and virulence.

Authors:  Shannon Weiman; Satoshi Uchiyama; Feng-Ying C Lin; Donald Chaffin; Ajit Varki; Victor Nizet; Amanda L Lewis
Journal:  Biochem J       Date:  2010-05-13       Impact factor: 3.857

Review 3.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

Review 4.  Two-Component Signal Transduction Systems in the Human Pathogen Streptococcus agalactiae.

Authors:  Lamar Thomas; Laura Cook
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 5.  Neonatal brain infections.

Authors:  Jacques F Schneider
Journal:  Pediatr Radiol       Date:  2011-04-27

6.  Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis.

Authors:  Wolfgang Ernst; Nicole Zimara; Frank Hanses; Daniela N Männel; Birgit Seelbach-Göbel; Anja K Wege
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

Review 7.  A journey into the brain: insight into how bacterial pathogens cross blood-brain barriers.

Authors:  Mathieu Coureuil; Hervé Lécuyer; Sandrine Bourdoulous; Xavier Nassif
Journal:  Nat Rev Microbiol       Date:  2017-01-16       Impact factor: 60.633

8.  IL-1β and Inflammasome Activity Link Inflammation to Abnormal Fetal Airway Development.

Authors:  Ashley N Stouch; Alyssa M McCoy; Rachel M Greer; Omar Lakhdari; Fiona E Yull; Timothy S Blackwell; Hal M Hoffman; Lawrence S Prince
Journal:  J Immunol       Date:  2016-03-07       Impact factor: 5.422

9.  The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates.

Authors:  Asmaa Tazi; Olivier Disson; Samuel Bellais; Abdelouhab Bouaboud; Nicolas Dmytruk; Shaynoor Dramsi; Michel-Yves Mistou; Huot Khun; Charlotte Mechler; Isabelle Tardieux; Patrick Trieu-Cuot; Marc Lecuit; Claire Poyart
Journal:  J Exp Med       Date:  2010-10-18       Impact factor: 14.307

10.  Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract.

Authors:  Prathiba Kurupati; Claire E Turner; Ioanna Tziona; Richard A Lawrenson; Faraz M Alam; Mahrokh Nohadani; Gordon W Stamp; Annelies S Zinkernagel; Victor Nizet; Robert J Edwards; Shiranee Sriskandan
Journal:  Mol Microbiol       Date:  2010-02-10       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.